.Attributes Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- medication conjugate (ADC) tisotumab vedotin resulted in boosted progression-free and also total survival, causing FDA approval and also a brand-new treatment alternative for individuals.